| Financial Year |
March 31 2023 |
| Monetary Funds |
914,920,153.33 |
| Held-for-trading Financial Assets |
662,339,398.52 |
| Notes Receivable |
7,325,750.95 |
| Accounts Receivable |
1,069,208,275.54 |
| Advances to Suppliers |
33,020,540.45 |
| Other Receivables |
33,511,327.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
888,594,779.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
114,961,347.70 |
| Total Current Assets |
3,723,881,572.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,175,231.58 |
| Investment Properties |
-- |
| Fixed Assetes |
660,328,882.58 |
| Under-construction Projects |
215,611,649.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
129,266,024.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,834,043.90 |
| Deferred Income Tax Assets |
99,687,336.96 |
| Other Non-Current Assets |
660,846,773.62 |
| Sub-Total of Non-Current Assets |
1,858,703,189.92 |
| Total Assets |
5,582,584,762.82 |
| Short-Term Loans |
302,990,018.00 |
| Trading Financial liabilities |
2,563,450.02 |
| Notes Payable |
413,942,240.70 |
| Accounts Payable |
1,077,917,359.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
153,831,578.30 |
| Taxes Payable |
21,438,627.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
98,213,645.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,157,096.06 |
| Other Current Liabilities |
1,837,705.60 |
| Sub-Total of Current Liabilities |
2,130,922,352.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
63,550,526.58 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
6,838.51 |
| Sub-Total of Non-Current Liabilities |
85,550,482.90 |
| Total Liabilities |
2,216,472,835.29 |
| Paid-In Capital(Or Share Stock) |
503,450,000.00 |
| Capital Surplus |
844,320,651.30 |
| Surplus Reserve |
26,774,336.06 |
| LESS:Treasury Stock |
28,221,000.00 |
| Undistributed Profits |
2,022,229,800.35 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,366,111,927.53 |
| Owner's Equity（Stockholder's Equity） |
3,366,111,927.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,582,584,762.82 |
